This clone was also reactive against patient-derived AML cells (AML 8278) naturally expressing DNMT3AR882H, whereas it failed to react against HLA-A*01:01-positive patient-derived AML cells with wildtype DNMT3A (AML 5205). The gene discussed is DNMT3A; the disease is acute myeloid leukemia.